Volume 12, Issue 2, March 2018

Index

PRACTICE GUIDELINES

Opportunities and challenges in oncology and molecular testing: the Belgian strategy

A. Hébrant, E. Van Valckenborgh, R. Salgado, G. Froyen, F. Hulstaert, D. Roberfroid, S. Tejpar, A. Jouret-Mourin, M. Van den Bulcke, A. Waeytens


Prevention of chemotherapy-induced nausea and vomiting: Belgian antiemetic treatment options anno 2018

W. Lybaert, P. Clement, K. Punie, J. Mebis, M. Renard, H. Wildiers


Second-line treatment of non-small cell lung cancer adenocarcinoma patients not harbouring an oncogene driver mutation anno 2017–2018: A consensus group meeting

P-E. Baugnée, L. Bosquée, C. Compère, N. D’Haene, I. Demedts, D. Galdermans, P. Germonpré, M. Gustin, V. Ninane, S. Ocak, P. Pauwels, T. Pieters, A. Sadowska, A. Sibille, V. Surmont, J. Vansteenkiste


ONCOCASE

Primary leiomyosarcoma of the thyroid: case report and review of the literature

E. Verhelst, S. De Schepper, S. Declercq, D. Schrijvers


ONCOTHESIS

Exploring extracellular vesicles for siRNA delivery and Raman-based diagnostics

S. Stremersch, S. De Smedt, K. Braeckmans, K. Raemdonck


CONGRESS NEWS

Highlights of Scientific Summits Meeting

M. Waterschoot, B. Hermans, M. Claessens, K. Decaestecker, G. De Meerleer, L. Goeman, S. Joniau


REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

P. Specenier


X